Pharmaceutical solutions & Specialty ingredients

About SEQENS group

Our main activities

A leader in
Pharmaceutical synthesis

Discover

A strong expertise in
Specialty Ingredients

Discover

A complete and integrated
R&D offer

Discover

committed to developing and sustainably producing
the solutions, technologies and essential molecules of tomorrow

Discover

Newsroom

#Live

General / Press Release

SEQENS and RONDOL partner in formulation research and continuous manufacturing for more effective treatments and more efficient supply chains.

This collaboration is based on the complementarity between the two companies, SEQENS as a global leader in small molecules Active Pharmaceutical Ingredients (APIs),…
Read more See all news
General

SEQENS obtains the label "Employer of Choice" from Engagement Jeunes

This year, Engagement Jeunes rewards SEQENS for its commitment to its interns and apprentices. The company was rated very positively by the young…
Read more See all news
General / Press Release

SEQENS and Rondol Group are pleased to announce their collaboration in formulation research and continuous flow manufacturing for existing, repurposed or new drugs

This collaboration is based on the complementarity between the two companies, with Seqens bringing its skills and expertise as a global leader in…
Read more See all news

#Jobs

See all our offers

Seqens global presence

Use interactive map
0

Employees

0

Scientists, experts and engineers

0

Manufacturing sites

0

Customers in more than 80 countries